Welcome to our dedicated page for Vision Sensing Acquisition news (Ticker: VSAC), a resource for investors and traders seeking the latest updates and insights on Vision Sensing Acquisition stock.
Vision Sensing Acquisition Corp. (NASDAQ: VSAC) is a blank check company, also known as a special purpose acquisition company (SPAC). Formed with the intention of facilitating a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, VSAC stands out in the financial markets due to its strategic objectives and forward-looking approach.
Recently, Vision Sensing Acquisition Corp. announced a definitive Agreement and Plan of Merger with Mediforum Co., Ltd, a renowned biotechnology company based in Korea. Mediforum specializes in the research and development of ethical drugs, diagnostic reagents, and strategic application products. This proposed business combination aims to leverage the strengths of both entities, promising significant advancements in the biotech sector.
Upon closing of the merger, the combined entity is expected to be publicly listed on NASDAQ under a new ticker symbol, highlighting a new chapter in their corporate journey. This move reflects VSAC’s commitment to identifying and partnering with innovative firms that have the potential to deliver substantial value to shareholders.
VSAC’s current operations and financial strategies are geared towards ensuring successful mergers and acquisitions, thereby creating robust investment opportunities for stakeholders. The company's recent partnership with Mediforum is a testament to its adeptness in recognizing and aligning with high-potential companies in growth industries.
For further inquiries:
- Chankyu Kim, Chairman and Founder, Mediforum (kimchankyu@gmediforum.com)
- Jae Eon Jung, CEO, Mediforum (jejung@gmediforum.com)
- Jason Wong, Chairman and CEO, Norwich Capital Limited (enquiry@norwichhk.com)
Vision Sensing Acquisition Corp (NASDAQ: VSAC) has announced the suspension of its securities from trading after October 25, 2024. The company will pay a per-share redemption price of $11.84 to holders of public shares on October 30, 2024. Following notification to Nasdaq on October 8 about failure to deposit required extension fees, VSAC is seeking voluntary delisting.
The company's trust account balance stands at approximately $13,427,746.07 as of October 18, with 1,133,691 remaining public shares. $100,000 will be retained for dissolution expenses, and $88,102 will be used for tax payments. Beneficial owners holding shares in 'street name' need not take action to receive redemption amounts. Company warrants will expire worthless.
Vision Sensing Acquisition Corp (NASDAQ: VSACU, VSAC, VSACW) announced its delisting and liquidation due to failure to complete a business combination by the required deadline. Key points:
1. The Sponsor did not deposit the extension fee by October 3, 2024.
2. VSAC will voluntarily delist from Nasdaq.
3. The company will dissolve and liquidate as per its charter.
4. Public shareholders will receive approximately $11.92 per share in redemption.
5. The trust account balance as of October 18, 2024, was about $13,515,848.07.
6. There were 1,133,691 public shares outstanding as of October 18, 2024.
7. Warrants will expire worthless.
8. The company will cease all operations except for winding up after October 21, 2024.
Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW), a special purpose acquisition company, has announced its intention to extend the deadline for completing its initial business combination from October 3, 2024, to November 3, 2024. This marks the sixth and final one-month extension authorized under the company's amended certificate of incorporation.
To facilitate this extension, the company's sponsor, Vision Sensing, , plans to deposit $51,016.10 into the company's trust account by July 3, 2024. In exchange, the company will issue a non-interest bearing, unsecured promissory note to the sponsor for the same amount. This extension aims to provide Vision Sensing Acquisition Corp. with additional time to finalize an initial business combination.
Vision Sensing Acquisition Corp. (NASDAQ: VSAC) has announced a payment to extend its deadline for completing an initial business combination. The company's sponsor, Vision Sensing, , deposited $51,016.10 into the trust account on August 2, 2024. This extension moves the deadline from September 3, 2024, to October 3, 2024.
This marks the fifth of six possible one-month extensions allowed under the company's recently amended certificate of incorporation. The extension provides Vision Sensing Acquisition Corp. with additional time to finalize a business combination. The amendment allowing these extensions was made on April 30, 2024.
Vision Sensing Acquisition Corp. (NASDAQ: VSAC) has announced its intention to extend the deadline for completing its initial business combination from September 3, 2024, to October 3, 2024. This marks the fifth of six possible one-month extensions authorized under the company's amended certificate of incorporation. To facilitate this extension, Vision Sensing, , the company's sponsor, plans to deposit $51,016.10 into the trust account by July 3, 2024. In exchange, the company will issue a non-interest bearing, unsecured promissory note to the sponsor for the same amount. This extension aims to provide Vision Sensing Acquisition Corp. with additional time to finalize an initial business combination.
Vision Sensing Acquisition Corp. (VSAC) has terminated its agreement with Mediforum Co., and entered into a non-binding letter of intent with Convergence CT, Inc. (CCT) for a business combination. The deal values CCT at $135 million, with $110 million paid upfront and the remainder subject to an earn-out. CCT specializes in smart hospital information systems and optimizing hospital workflows using IoT and AI. The combined company is expected to trade on NASDAQ post-closing. The transaction includes a 6-month lock-up period for issued shares and the formation of a 5-member board of directors. The parties aim to sign a binding agreement by August 31, 2024.
Vision Sensing Acquisition Corp. (NASDAQ: VSAC) has announced a significant development in its pursuit of an initial business combination. The company's sponsor, Vision Sensing, , has deposited $51,016.10 into the trust account to extend the deadline for completing the combination from August 3, 2024, to September 3, 2024. This marks the fourth of six possible one-month extensions allowed under the company's recently amended certificate of incorporation.
The extension is important for Vision Sensing Acquisition Corp. as it provides additional time to finalize its Business Combination with Mediforum Co. , a Korean company. This merger agreement, initially dated January 12, 2024, is now given more time for completion. The move demonstrates the company's commitment to ensuring a successful merger and highlights the complex nature of international business combinations in the SPAC sector.
Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW), a special purpose acquisition company, has announced its intention to extend the deadline for completing its initial business combination from August 3, 2024, to September 3, 2024. This marks the fourth of up to six one-month extensions authorized under the company's amended certificate of incorporation. To facilitate this extension, the company's sponsor, Vision Sensing, , plans to deposit $51,016.10 into the trust account by July 3, 2024. In return, the company will issue a non-interest bearing, unsecured promissory note to the sponsor. This extension is aimed at providing additional time for Vision Sensing to complete its initial business combination, which is currently planned with Mediforum Co. , a Korean company, under an Agreement and Plan of Merger dated January 12, 2024.
Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) has successfully applied to migrate from the Nasdaq Global Market to the Nasdaq Capital Market, effective July 19, 2024. This move comes after a series of events, including a delisting notice in January 2024, regaining compliance with Listing Rule 5250(c)(1) in February, and a Nasdaq Hearings Panel granting an extension to transfer listings by July 15, 2024. The company has taken steps to meet Nasdaq Capital Market requirements, including converting 2,530,000 Series B shares into Series A shares to comply with the Market Value of Listed Securities Requirement. VSAC's management presented a viable plan to regain compliance while pursuing a business combination, demonstrating their commitment to maintaining their Nasdaq listing.
Vision Sensing Acquisition Corp. (NASDAQ: VSAC) has announced it has extended the deadline to complete its initial business combination to August 3, 2024. The extension was made possible by a $51,016.10 deposit made by its sponsor into the company’s trust account on July 2, 2024. This marks the third out of six possible one-month extensions permissible under the company's amended certificate of incorporation as of April 30, 2024.
The purpose of the extension is to provide the company additional time to finalize its merger with Mediforum Co. , a Korean company, as per the merger agreement signed on January 12, 2024. The company aims to use this extra time to ensure a smooth and successful completion of the business combination.
FAQ
What is the current stock price of Vision Sensing Acquisition (VSAC)?
What is the market cap of Vision Sensing Acquisition (VSAC)?
What is Vision Sensing Acquisition Corp.?
What is the latest news about VSAC?
Who is Mediforum Co., Ltd?
What will happen after the merger with Mediforum?
What is a blank check company?
How does VSAC create value for shareholders?
Who are the key contacts for the merger with Mediforum?
What is the primary business of VSAC?
When is the merger with Mediforum expected to be completed?